A detailed history of Ci Investments Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 11,928 shares of RXRX stock, worth $77,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,928
Previous 6,098 95.61%
Holding current value
$77,174
Previous $40,000 102.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$5.7 - $8.27 $33,231 - $48,214
5,830 Added 95.61%
11,928 $81,000
Q3 2024

Nov 12, 2024

BUY
$5.92 - $8.6 $272 - $395
46 Added 0.76%
6,098 $40,000
Q2 2024

Aug 12, 2024

BUY
$7.35 - $10.05 $44,482 - $60,822
6,052 New
6,052 $45,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.17B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.